![]() |
Volumn 131, Issue 10, 2013, Pages 1265-1266
|
Genetic testing for inherited eye disease who benefits?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOCHROME P450 1B1;
MITOCHONDRIAL DNA;
MYOCILIN;
TRANSCRIPTION FACTOR FOXC1;
TRANSCRIPTION FACTOR PAX6;
TRANSCRIPTION FACTOR PITX2;
3' UNTRANSLATED REGION;
5' UNTRANSLATED REGION;
ANIRIDIA;
AUTOSOMAL DOMINANT OPTIC ATROPHY;
CHROMOSOME ABERRATION;
CHROMOSOME TRANSLOCATION;
CLINICAL EVALUATION;
CONGENITAL GLAUCOMA;
DISEASE TRANSMISSION;
DNA SEQUENCE;
DOMINANT INHERITANCE;
ENDOPLASMIC RETICULUM STRESS;
EYE DISEASE;
FAMILIAL DISEASE;
GENE MUTATION;
GENE THERAPY;
GENETIC COUNSELING;
GENETIC SCREENING;
GLAUCOMA;
HETEROZYGOTE DETECTION;
HUMAN;
KARYOTYPING;
LEBER CONGENITAL AMAUROSIS;
LEBER HEREDITARY OPTIC NEUROPATHY;
MOLECULAR DIAGNOSIS;
MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION;
NEPHROBLASTOMA;
NOTE;
OPTIC NERVE ATROPHY;
OPTIC NERVE DISEASE;
PHENOTYPE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RETINA DEGENERATION;
RETINITIS PIGMENTOSA;
RETINOBLASTOMA;
RISK ASSESSMENT;
STARGARDT DISEASE;
EYE DISEASES, HEREDITARY;
EYE PROTEINS;
FAMILY HEALTH;
GENETIC COUNSELING;
GENETIC TESTING;
GLAUCOMA;
HUMANS;
OPTIC NERVE DISEASES;
PRACTICE GUIDELINES AS TOPIC;
RETINAL DEGENERATION;
RISK ASSESSMENT;
|
EID: 84885931362
PISSN: 21686165
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaophthalmol.2013.4509 Document Type: Note |
Times cited : (23)
|
References (7)
|